Skip to main content

Table 3 Outcomes of tracing of the 136 ART-eligible patients who were considered lost to follow-up and not known to have died

From: Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa

Results No.
Did not complete ART preparation because of "disclosure" issue 54 (40%)
Subject has relocated out of The Gambia 11 (8%)
Receiving care in another health care facility 4 (3%)
Has opted for traditional treatment 4 (3%)
"Don't want Antiretroviral therapy" 14 (10%)
Not found at field visit 35 (26%)
Subject gave no reason but refused to attend clinic 14 (10%)